Global Over The Counter (OTC) Drugs Market

The report "Over the Counter (OTC) Drugs Market, by Product Type (Analgesics, Cough, Cold and Flu
Products, Dermatological Products, Gastrointestinal Products, Vitamins, Minerals, Weight Loss
Products, Sleep Aids, Ophthalmic Products, Smoking Cession Aids and Other Products)-Forecast to
2022", The Over the Counter Drugs market is expected to reach USD 243 Billion by 2022 from an
estimated USD 148 Billion in 2016, at a CAGR of 8.55%.
Browse through 176 Pages and in-depth TOC on "Over the Counter(OTC)
[email protected]://
Early buyers will receive 10% customization on reports.
By Product Type, half of the market share belongs to categories like Analgesics, Cough, Cold & Flu,
Dermatological and gastrointestinal categories in the forecast period of 2017-2022.
On the basis of product type, the genomics market has been segmented into a wide variety of products
such as Analgesics, Cough, Cold and Flu Products, Dermatological Products, Gastrointestinal Products,
Vitamins, Minerals, Weight Loss Products, Sleep Aids, Ophthalmic Products, Smoking Cession Aids and
Other Products
Customized Report:
OTC drugs are developed under OTC Monograph process or through New Drug Application (NDA)
process. These drugs come with a monograph on which the ingredients of the drug, dosage and user
instructions are written. Easy availability, lesser prices, convenience, user-empowering qualities are the
benefits of OTC drugs. With the growing number of chemists and pharma dispensaries, the drugs are
readily accessible.
Public started showing pro-active approach towards the illnesses. Alongside that, they are additionally
turning to bring down evaluated choices because of bringing costs up in medicinal services. The social
move out in the open towards confidence leads in increasing real acquisitions. These are a portion of the
drivers that shoot up the market development. Be that as it may, the market development is prevented
because of the issue of medication substance manhandle and absence of mindfulness in immature
North America dominated the market in 2017
Request Sample:
North America leads the market closely followed by Europe and Asia Pacific region. Though the market is
predicted to decline in the near future due to increase in the number of generic medication. Asia-Pacific
regions like China, Japan an India are fastest growing markets, as the growing rate is going at an
exponential rate.
GlaxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, GSK Boehringer Ingelheim, Sanofi, Takeda
and PGT Healthcare are the top companies that contribute to OTC drugs market. The maximum market
share is possessed by GlaxoSmithKline, Johnson and Johnson, Novartis and Sanofi. The extension of OTC
service for the drugs dealing with chronic diseases like diabetes and hypertension is a new trend to be
About MarketDataForecast™-
Market Data Forecast is a market research firm offering syndicated research, consults and industry
newsletters across various domains & verticals. With a well-established in-house team of experts from
diverse fields and outsource research network across 100+ countries, we are the sole research providers
for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence,
our unique services like free customization, analyst support for the period of six months post to the
purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth
understanding of various business environments will be a support to you and your organization in making
well-informed decisions.
Related Link:
Contact Info:
Name: Mr. Abhishek Shukla
Email: [email protected]
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

The Global OTC drugs market has been estimated at USD 148,917.6 Million in 2016 and is projected to reach USD 243,686.1 Million by 2022, at a CAGR of 8.55% during the forecast period from 2016 to 2022.